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for
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David A. Relman

The distributionand diversity of microorganismsin the world are far
greater than have been previously appreciated. Molecular,cultivationindependent methods have played a key role in this insight. To what
extent do humansremainignorantof microbialdiversitywithinthe human
body and the settings in which microorganismscause human disease? In
additionto implicatingmicrobialagents in nontraditionalinfectious diseases, the use of methods such as broad-rangepolymerasechain reaction,
representationaldifferenceanalysis,expressionlibraryscreening,and host
gene expression profilingmay force a reassessment of the concepts of
microbialdisease causation.

that are complimentaryto genomic sequences
conserved among all family members (7).
The approach is also amenable to highthroughputmethods. However, the advantages of broad-rangePCR are partiallyoffset by
the problem of microbial DNA contamination. BacterialrDNA can be detected in clinical specimens from sterile sites of healthy
individuals (for example, blood samples).
Possible explanations include PCR reagent
contamination, contamination of the speciWithin the world of cultivated bacteria, vicauses of Crohn's disease, ulcerative colitis, men during collection, and the presence of
ruses, and unicellulareukaryotesthat inhabit Wegener's granulomatosis, rheumatoid ar- bacteria or their DNA within sterile sites
the human body, the number and variety of
thritis, tropical sprue, systemic lupus ery- despite the absence of apparentdisease. Few
relations between microbe and host are thematosus, Kawasaki's disease, and other investigations have addressed this third, but
breathtaking.Yet, surveys of many terrestrial chronicdiseases remainunknowndespite dis- most intriguing,possibility.
Other genotypic pathogen discovery apease featuresthat are suggestive of infectious
and aquatic ecosystems indicate that >99%
proachescomplementthe advantagesand disof microorganismsresist cultivation in the etiology.
laboratoryand can only be identified or charadvantagesof broad-rangePCR. RDA relies
on subtractive hybridization to isolate rare
acterizedwith the use of molecularapproach- Search Methods
es (1). We presumeto know much about the Relying on an infectious agent to "perform" genomic fragments (from an exogenous inecosystem most intimatelyrelatedto our very in the laboratoryfor the purposesof detection fectious agent) found in one (infected) specexistence-the microbial world within the and identificationposes a numberof potential imen but not in an otherwise matched (uninhumanbody. Nearly all available information pitfalls. Identificationof infectious agents by
fected) specimen. With a subsequent PCR
aboutthe compositionof the endogenousmi- phenotypic traits is insensitive, because we
step, these rare fragmentsare enriched. With
croflora and the role of microorganisms in are largely ignorant of the environmental RDA, one addressesthe problemof specimen
human disease has been based on laboratory conditions requiredby some microorganisms contaminationand endogenous microbial secultivation. Are we as ill-informed about for growth and, hence, are unable to replicate quences by using a matched specimen to
these human-associatedsegments of the mi- them in the laboratory.Phenotypic traits are reduce the presence of sequences that are
crobial world? We would expect this not to
common to the two specimens; however,
also difficult to quantitate,and they can be
be the case, because such a large effort is
misleading. In contrast,genotypic traits genunique genomic fragmentsfrom the infected
dedicatedto microbialidentificationonce hu- erally provide reliable and quantifiableinfor- specimen are enrichedin a nonselective manmans develop clinical signs of infection. But, mationfor the identificationand characteriza- ner. These fragmentsmay not provide specifa number of observationssuggest inadequa- tion of infectious agents. Moreover,genotyp- ic information about the putative pathogen;
that is, not all genome sequences provide a
cies in currentdiagnosticmethods. The ensu- ic traits such as genomic sequence can be
ing discussion describes alternativemethods analyzed directly in clinical specimens, with- useful view of phylogenetic history. With
that have the potential to enhance the recog- out purification or isolation of the agent. expression libraiy screening, pathogen-denition and characterizationof microbial dis- Among the proven genotypic approachesfor rived genomic fragmentsare identified from
detectingand identifyingpreviouslyunrecog- infected sites using host antisera,but only if
ease, as well as to change the way we view
disease causation.
nized pathogens are broad-rangepolymerase the fragments encode antigenic products.
The traditionaldiagnosticapproachof isochain reaction(PCR), representationaldiffer- Disease accompanied by autoreactive antilating the etiologic agent or demonstratinga ence analysis (RDA), and expression library bodies might pose additionalproblems.Some
substantialchange in antibody titer to a spe- screening (2, 3). With broad-rangePCR, one of the pathogens revealed with these apcific pathogen requires some understanding amplifies genetic loci whose sequences pro- proaches are listed in Table 1.
of growth conditions or specific antigenic vide reliable phylogenetic informationabout
Any comprehensive pathogen detection
determinants.Yet, these requirementshave an infectious agent, using priming sites that effort faces additional challenges. In some
limited our ability to recognize and identify are conserved among broadgroups of agents. instances, microorganisms cause disease
microbial pathogens. Beginning with the One of the most useful loci is the gene that from a distance. For example, toxic shock
work of RobertKoch in the late 19thcentury, encodes the small subunit ribosomal RNA. syndrome results from superantigen toxins
generations of epidemiologists, clinicians, An extensive microbial ribosomal DNA
released by Staphylococcusaureus or Strepand pathologists have confronted the same (rDNA) sequence databaseenhances the usetococcuspyogenes strainsthat can be sequesobstacles in their quest to explain disease fulness of this markerfor diagnostic discrim- tered at unsuspectedanatomic sites, and botpatternsthatare reminiscentof infection. The ination and resolution. For example, previ- ulism usually occurs after ingestion of only
ously unrecognizedmembers of the bacterial the toxin. In other instances, infection inidomain can be identified with primers that tiates an immunologicresponsethatresults in
Departmentof Medicine,Departmentof Microbiology recognize all bacterial small subunit rDNAs
disease after the causative agent has been
and Immunology,StanfordUniversity,Stanford,CA
cleared
from the host. For example, Campyand
famiamplify
specific
sequences
(4-6);
94305, USA;VA PaloAlto HealthCareSystem 154T,
lobacterjejuni is proposedto cause Guillain3801 MirandaAvenue, Palo Alto, CA 94304, USA. lies of viruses can be explored with the
E-mail:relman@cmgm.stanford.edu
broad-range PCR approach, using primers Baire syndrome,an acute inflammatoryneu1308
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MICROBES,
ropathy,by eliciting cross-reactiveantibodies
to ganglioside that damage peripheralnerves
weeks to months after intestinalinfection (8).
In all of these instances,nucleic acid from the
pathogen would not be expected at sites of
pathology or in the bloodstream.Of course,
detection of nucleic acid does not indicate
viability of the putative agent.
To meet some of these challenges, one
might turn instead to the host as a source of
infection-specific genotypic information. In
collaborationwith PatrickBrown at Stanford
University and Lou Staudt at the National
Cancer Institute, we are collecting and analyzing humangene expression responses to a
wide variety of infectious agents and other
noxious stimuli using microarrayscontaining
complementaryDNA (cDNA) for >15,000
human genes. cDNA microarrays measure
steady-statemessenger RNA (mRNA) abundance in a miniaturized, massively parallel
hybridizationformat.Comparisonsof mRNA
levels in multiple samples are accomplished
with differential fluorescence labeling (9).
Our hypothesis is that microbial pathogens
induce stereotypic mRNA response profiles
that can be used to distinguishamong different infectious agents or differentpathogenetic
mechanisms (2, 10). The complex repertoire
of potential human gene transcriptionalresponses provides a far greaterdegree of specificity thando the traditionalmarkersof acute
inflammation, such as cytokines and acutephase proteins like C-reactive protein (11).
The goal with this approachis to recognize
diagnostic signatures in clinical specimens
from unexplained illness that would reveal
the etiologic agent and the time of initial host
exposure. With this approach,infectious diseases might be classified in a radicallydifferent manner, on the basis of how a particular
host "sees" an integrated collection of virulence mechanisms.
Where to Look?
A wide range of acute and chronic diseases
and syndromes warrants broad cultivationindependent searches for microbial pathogens. In short,there is a substantialamountof
unexplainedillness that resembles infectious
disease. For example, most clinicians are familiar with a scenario in which a previously
healthy individual develops an acute lifethreateningillness with signs of infection and
negative diagnostic test results. One of the
first efforts to identify and analyze such cases
is the Unexplained Deaths project coordinated by the Centers for Disease Control and
Prevention (12). Our results from this ongoing projectindicatethat (i) unexplaineddeath
or critical illness occurs in 0.5 to 2.0 persons
per 100,000 population in the United States
per year, (ii) broad-range bacterial rDNA
PCR reveals known disease-causingagents as
a probableor definite pathogen in some cas-
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Table 1. Examplesof human disease and associated microbial pathogens revealed during the past 15
years. All of these infectious agents, except Helicobacterpylori,were first identified directly from clinical
specimens using genotypic approaches.
Disease

Infectious agents

Reference

Peptic ulcer disease
Non-A, non-B hepatitis
Bacillaryangiomatosis
Whipple's disease
Hantaviruspulmonarysyndrome
Kaposi'ssarcoma

Helicobacterpylori
Hepatitis C virus
Bartonellahenselae
Tropherymawhippelii
Sin Nombre virus
Kaposi'ssarcoma-associated herpesvirus

(27)
(28)
(5)
(29)
(7)
(30)

es, and (iii) little thoughtor attentionhas been
directed at the selection and processing of
clinical specimens that are appropriatefor
molecular pathogen discovery approaches.
A number of chronic inflammatorysyndromes also bear the hallmarksof microbial
disease (some listed above) and are only now,
belatedly, the subjects of broad-rangemolecular pathogen identification methods (13).
Crohn's disease, for example, involves the
entire intestinalwall in a relapsing-remitting,
acute and chronic granulomatousinflammatory process (14). However, any effort to find
a microbial etiologic agent for Crohn's disease must address the issues of when and
where it might be found in the course of this
disease and how to deal with the complex,
dense host-specific backgroundof microorganisms within the intestines. Laser-capture
microdissection(15) could complementall of
the molecularapproachesdescribedabove by
focusing the search on suspect areas or cells

Plasticcap

within a tissue section and assisting with the
selection of a more closely matched control
sample (Fig. 1).
The commensal microflora has been
viewed as a source of specimen contamination and occasional opportunisticpathogens,
but it may play a more important role in
health and disease than was once thought.
The intestinal commensal flora is associated
with the pathogenesisof inflammatorybowel
disease such as Crohn's disease, with nontropical sprue, and other disorders;it is also
thought to play an essential role in intestinal
epithelial differentiation. The endogenous
flora of the mouth is associated with gingivitis, periodontitis, and systemic infections
such as endocarditis.Yet, we are largely ignorantof the compositionof and the temporal
and spatial dynamics within these microbial
communities(16, 17). This ignoranceresults
in part from an excessive reliance on microbial cultivation.A substantialproportionof hu-
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Fig. 1. A targeted broad-rangerDNAPCRapproachfor pathogen discoveryin Crohn'sdisease.
Laser-capturemicrodissectionallows one to isolate microscopicregions of tissue that have a
greaterlikelihoodof containingthe pathogen(for example,granulomataor infectedsingle cells).
Granulomataare chronicinflammatoryreactionsthat are frequentlyassociated with persistent
microorganismsor microbialantigen;they are found in tissues affected by Crohn'sand other
idiopathicdiseases. Anatomictargeting is particularlyimportantwhen there is gross microbial
contaminationof tissues, as in the intestinalwall from Crohn'sdisease. [Modifiedfrom Fig.1 by
Bonneret al. (15); histopathologycourtesyof DonaldRegula(StanfordUniversity).]
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man-associatedmicroorganismsspendstime as
membersof biofihms(for example,on the surface of teeth).As Costertonet al. point out, the
sessile membersof biofihmsassumephysiological statesthatrenderthem resistantto cultivation (18). With sensitive genotypic methods,
one task will be to identifythe previouslyunrecognizedmembersof our endogenousmucosal and cutaneousflora and then to tracktheir
possible translocationto othersites. For example, do chlamydiaroutinelytrafficto vascular
endothelia?Despitethe recognizedpresenceof
archaea (methanogens)within the alimentary
tract,why haveno archaeabeen incriminatedas
pathogens?Are we not looking with appropriate methodsin the right places? Anothertask
will be to characterizequantitativeand qualitative differencesin communitycompositionbetween differentanatomicniches and hosts and
changesover time.
Ecological concepts such as population
heterogeneityand density may be critical in
the transitionfrom health to disease (for example, from plaque-associated gingivitis to
adult-onsetperiodontitis).We will need new
types of clinical measurements that reflect
ecosystem health and stability (19). Our understanding of endogenous microflora may
also require reassessment. For example, unsuspected endosymbiotic rickettsia-like Wolbachia species have been discovered in nematodes and have been found to play a role in
host development (20). As we explore the
details of the human genome and apply sensitive pathogen detection methods to human
specimens, we should keep in mind the possible clinical relevance of cryptic and not-socryptic human endogenous retroviruses(21).
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function. In these situations,the linkage be- obvious payoff will be the reassessment of
tween microbe and disease is not linear and our relations with infectious agents and the
unidirectional.Genotype-basedapproachesthat way we view microbial disease causation.
are quantitative,sensitive,and high throughput
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